However, in the late cohort, more patients were treated with ACE-inhibitors/angiotensin receptor blockers, calcium channel blockers and oral anticoagulants (Table 2), which could suggest an overall better management of hypertension, heart failure and atrial fibrillation. Here, ACE is linked to atrial fibrillation.